Matches in Wikidata for { <http://www.wikidata.org/entity/Q96772781> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- Q96772781 description "2020 nî lūn-bûn" @default.
- Q96772781 description "2020年の論文" @default.
- Q96772781 description "2020年学术文章" @default.
- Q96772781 description "2020年学术文章" @default.
- Q96772781 description "2020年学术文章" @default.
- Q96772781 description "2020年学术文章" @default.
- Q96772781 description "2020年学术文章" @default.
- Q96772781 description "2020年学术文章" @default.
- Q96772781 description "2020年學術文章" @default.
- Q96772781 description "2020年學術文章" @default.
- Q96772781 description "2020年學術文章" @default.
- Q96772781 description "2020年學術文章" @default.
- Q96772781 description "2020年學術文章" @default.
- Q96772781 description "2020년 논문" @default.
- Q96772781 description "article científic" @default.
- Q96772781 description "article scientific" @default.
- Q96772781 description "article scientifique" @default.
- Q96772781 description "articol științific" @default.
- Q96772781 description "articolo scientifico" @default.
- Q96772781 description "artigo científico" @default.
- Q96772781 description "artigo científico" @default.
- Q96772781 description "artigo científico" @default.
- Q96772781 description "artikel ilmiah" @default.
- Q96772781 description "artikull shkencor" @default.
- Q96772781 description "artikulong pang-agham" @default.
- Q96772781 description "artykuł naukowy" @default.
- Q96772781 description "artículo científico publicado en 2020" @default.
- Q96772781 description "artículu científicu" @default.
- Q96772781 description "bilimsel makale" @default.
- Q96772781 description "bài báo khoa học" @default.
- Q96772781 description "naučni članak" @default.
- Q96772781 description "scienca artikolo" @default.
- Q96772781 description "scientific article published on 28 June 2020" @default.
- Q96772781 description "scientific article published on 28 June 2020" @default.
- Q96772781 description "scientific article published on 28 June 2020" @default.
- Q96772781 description "teaduslik artikkel" @default.
- Q96772781 description "tieteellinen artikkeli" @default.
- Q96772781 description "tudományos cikk" @default.
- Q96772781 description "vedecký článok" @default.
- Q96772781 description "vetenskaplig artikel" @default.
- Q96772781 description "videnskabelig artikel udgivet 28. juni 2020" @default.
- Q96772781 description "vitenskapelig artikkel" @default.
- Q96772781 description "vitskapeleg artikkel" @default.
- Q96772781 description "vědecký článek" @default.
- Q96772781 description "wetenschappelijk artikel" @default.
- Q96772781 description "wissenschaftlicher Artikel" @default.
- Q96772781 description "επιστημονικό άρθρο" @default.
- Q96772781 description "мақолаи илмӣ" @default.
- Q96772781 description "наукова стаття, опублікована в червні 2020" @default.
- Q96772781 description "научна статия" @default.
- Q96772781 description "научная статья" @default.
- Q96772781 description "научни чланак" @default.
- Q96772781 description "научни чланак" @default.
- Q96772781 description "מאמר מדעי" @default.
- Q96772781 description "مقالة علمية نشرت في 28 يونيو 2020" @default.
- Q96772781 description "২৮ জুন ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q96772781 description "บทความทางวิทยาศาสตร์" @default.
- Q96772781 description "სამეცნიერო სტატია" @default.
- Q96772781 name "Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial" @default.
- Q96772781 name "Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial" @default.
- Q96772781 type Item @default.
- Q96772781 label "Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial" @default.
- Q96772781 label "Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial" @default.
- Q96772781 prefLabel "Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial" @default.
- Q96772781 prefLabel "Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial" @default.
- Q96772781 P1433 Q96772781-A0A31BDF-738F-4009-9750-3AC7A7F453B9 @default.
- Q96772781 P1476 Q96772781-3DBB6525-47BF-41C9-BA81-E79D71AF0394 @default.
- Q96772781 P2093 Q96772781-08D87C54-F908-418E-B954-51E6738E4F0C @default.
- Q96772781 P2093 Q96772781-167A583A-C5E8-454A-B575-5062DFC63340 @default.
- Q96772781 P2093 Q96772781-BBB6CCAA-B6E5-46C4-912C-AB7C658AEDDC @default.
- Q96772781 P2093 Q96772781-C828B52B-F360-4C44-86E6-2D3CE3C656B7 @default.
- Q96772781 P2093 Q96772781-E69B30AF-6293-4D23-8ADE-1E8D51BD1037 @default.
- Q96772781 P2093 Q96772781-F87655B0-F6FC-406F-A6A1-6C4760F62AD5 @default.
- Q96772781 P31 Q96772781-E14E546D-1C3A-42B5-8DC1-B7BBCD5DBF54 @default.
- Q96772781 P356 Q96772781-009CFD35-2E44-47D9-A262-8D3F3E966C8C @default.
- Q96772781 P50 Q96772781-A0CF174F-2426-44A2-8C3A-37F4684802EE @default.
- Q96772781 P50 Q96772781-C055D9E3-0E20-4AD1-8E24-EEE282B1B474 @default.
- Q96772781 P577 Q96772781-DF5773C8-F9A7-45F2-8493-367004321FC1 @default.
- Q96772781 P698 Q96772781-151EECB8-6012-4821-AEA5-42A2501B6948 @default.
- Q96772781 P921 Q96772781-CCE49519-67B6-46DB-8E43-039636A51A89 @default.
- Q96772781 P932 Q96772781-C0C8031F-3F8B-43AF-BF95-E11E7AF455E2 @default.
- Q96772781 P356 BJD.19341 @default.
- Q96772781 P698 32594522 @default.
- Q96772781 P1433 Q4970191 @default.
- Q96772781 P1476 "Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial" @default.
- Q96772781 P2093 "M Kelly" @default.
- Q96772781 P2093 "R B Warren" @default.
- Q96772781 P2093 "S Beeck" @default.
- Q96772781 P2093 "T Wu" @default.
- Q96772781 P2093 "Y Poulin" @default.
- Q96772781 P2093 "Z Geng" @default.
- Q96772781 P31 Q13442814 @default.
- Q96772781 P356 "10.1111/BJD.19341" @default.
- Q96772781 P50 Q55602005 @default.
- Q96772781 P50 Q57038615 @default.
- Q96772781 P577 "2020-06-28T00:00:00Z" @default.
- Q96772781 P698 "32594522" @default.
- Q96772781 P921 Q10355321 @default.
- Q96772781 P932 "7983954" @default.